e-learning
resources
Munich 2006
Tuesday 05.09.2006
Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update
M. Luisetti, G. Stella, I. Campo, G. Rodi, A. Corsico, M. Ceruti, R. Dore, I. Cerveri, B. C. Trapnell, E. Pozzi (Pavia, Italy; Cincinnati, United States Of America)
Source:
Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Session:
Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Session type:
Oral Presentation
Number:
3334
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Luisetti, G. Stella, I. Campo, G. Rodi, A. Corsico, M. Ceruti, R. Dore, I. Cerveri, B. C. Trapnell, E. Pozzi (Pavia, Italy; Cincinnati, United States Of America). Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update. Eur Respir J 2006; 28: Suppl. 50, 3334
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 526-531
Year: 2004
Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005
What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease?
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Efficacy of total lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF
Source: International Congress 2016 – Advancements in bronchoscopy
Year: 2016
The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004
Longitudinal evaluation of airway inflammation in stable CF patients by bronchoalveolar lavage (BAL) and influence of rhDNAse
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001
Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid
Source: Eur Respir J 2004; 24: 964-970
Year: 2004
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003
The value of the whole lung lavage for patients with pulmonaryalveolar proteinosis
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009
Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept